Drucken - Print

Clinic for Internal Medicine (Tumor Research)


Prof. Dr. med. Martin Schuler

Director:

Prof. Dr. med. Martin Schuler

E-Mail:

martin.schuler@uk-essen.de

Office:

Dagmar Kolomak,
Silke Tiefenthaler

Phone:

+49 (0) 201-723-20 00

Fax:

+49 (0) 201-723-59 24

Homepage:

Clinic for Internal Medicine (Tumor Research)

Deputy Director:

Prof. Dr. med. Max Scheulen

 

Focus areas

Our clinic is one of the first of its kind dedicated to the pharmacological treatment of patients with malignancies and has been for decades.

Our clinical focus is on developing therapeutic strategies and applying pharmacological therapies as part of interdisciplinary treatment concepts for tumor patients, in particular with tumors of the lungs and the chest region, the gastrointestinal tract, the liver, the pancreas and biliary system, with breast cancer, ovarian cancer, with tumors of the head and neck region, with kidney, bladder, or germ cell tumors, with brain tumors, and tumors of bones and soft tissues. Another focus is on treating patients with cancers of unknown primary origin (CUP).

In addition to chemotherapy which continues to play an important role in tumor treatments, so-called targeted drugs such as monoclonal antibodies and tumor growth inhibitors have been developed. Our clinic has participated in introducing these agents into clinical practice, putting a different spin on modern cancer therapy. In addition, both the efficacy and safety of chemotherapy and radiation treatments have been significantly improved through concomitant medications and optimized drug combinations. The continued enhancement of these treatments as well as the development of new drugs in clinical trials is another focus area of the Clinic for Internal Medicine (Tumor Research). Last but not least, the palliative and pain relieving care of our patients, as well as the control of tumor complications, is particularly important to us. Physicians, nurses, and other professionals of the West German Tumor Center join us in providing these comprehensive, interdisciplinary services.

 

Special Consultations and Tumor Boards

  • Tumors of the chest region (in cooperation with the Radiation and Tumor Clinic [Klinik für Strahlentherapie] and Ruhrlandklinik Essen-Heidhausen)
  • Tumors of the abdominal region (West German Gastrointestinal Center)
  • Sarcomas (in cooperation with the Clinic for Emergency Surgery and the Radiation and Tumor Clinic [Klinik für Strahlentherapie])
  • Urogenital tumors (in cooperation with the Clinic for Urology)
  • Breast and ovarian cancer (in cooperation with the Women's Clinic)
  • Tumors of the head and neck region (in cooperation with the Ear, Nose, and Throat Clinic and the Radiation and Tumor Clinic [Klinik für Strahlentherapie])
  • Brain tumors (in cooperation with the Clinics for Neurosurgery and Neurology and the Radiation and Tumor Clinic [Klinik für Strahlentherapie])

 

Fields of Research

  • Development and clinical trials of new pharmacological tumor therapies
  • Research on the molecular, genetic, and immunologic principles of tumor development and treatment
  • Development of new diagnostic and prognostic factors

 

Number of patients

Inpatient: 3,930

Outpatient: 25,000

One-day inpatients: 3,220

 

Staff

The clinic's team consists of 23 physicians, including 15 specialists, and 50 nurses, 19% of whom have advanced specialized training in the clinics fields. In addition, there are 17 medical-technical employees in the outpatient clinics, in functional services and laboratories, 2 employees of the psychosocial service, 11 employees in documentation and administration, and more than 10 scientists.